Description:

Join the Querrey InQbation Lab for a conversation with Kathryn Kosuda WCAS ’10, co-founder of Vaxess Technologies, as she shares her journey from Northwestern graduate student to biotech entrepreneur. Vaxess was born out of an audited course at Harvard Business School and is built on transformative technology developed at Tufts and MIT. The company is pioneering a new model for delivering vaccines and therapeutics—one that extends beyond traditional healthcare settings to improve global access to life-saving medicines.

Kathryn will walk us through the evolution of Vaxess’s core technology and strategy, highlighting key inflection points in the company’s development. She will also reflect on the lessons learned in translating academic research into a venture-backed startup tackling major global health challenges.

This session will offer valuable insights for researchers, students, and aspiring entrepreneurs interested in scientific innovation, translational research, and the startup journey.

About the Speaker:
Kathryn Kosuda, PhD
Co-Founder, Chief Scientific Officer
Vaxess Technologies

With a background in chemistry and nanomaterials, Kathryn has focused on the translation of academic research breakthroughs into impactful products, working across disciplines of biology, chemistry, and engineering. Prior to co-founding Vaxess, Kathryn was a postdoctoral research fellow in the Department of Chemistry & Chemical Biology at Harvard. Kathryn began her career in research and development at Merck. She holds a BA in chemistry from Colby College and a PhD in Physical Chemistry from Northwestern University.